Recruiting CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol NCT05648019 Conditions B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more Locations Singapore General Hospital — Singapore KK Women's and Children's Hospital — Singapore View Trial Details
Recruiting CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia NCT05043571 Conditions CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +16 more Locations Allen Yeoh Eng Juh — Singapore View Trial Details
Recruiting ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. NCT05038696 Conditions CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +14 more Locations Allen Yeoh Eng Juh — Singapore View Trial Details
Active, Not Recruiting Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia NCT03155191 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more Locations Akita University Hospital — Akita, Japan University Of Fukui Hospital — Yoshida, Fukui, Japan Kyushu University Hospital — Higashiku, Fukuoka, Japan Hokkaido University Hospital — Sapporo, Hokkaido, Japan View more locations Show fewer locations Loading locations... View Trial Details
